Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Genome & Company

Equities

A314130

KR7314130006

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 23/05/2024 BST 		5-day change 1st Jan Change
8,070 KRW -4.83% Intraday chart for Genome & Company -10.33% -35.39%
01-24 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENOME & COMPANY
Other Biotechnology & Medical Research
-4.83%-10.33%-35.39%-57.12%-83.55% 89.25M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Charts Genome & Company
  5. Comparison Chart